IL22 and chronic obstructive pulmonary disease: In terms of potential therapeutic interventions targeting airway dysbiosis, reducing airway concentration levels of indole-3-acetic acid (IAA), derived from Lactobacillus spp., upregulated interleukin-22 signaling and epithelial cell apoptosis pathways in COPD [42].